Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2019-09-18, Stock:ABBV, The news for the past five days is as follows:
2019-09-11: NEWS1: Noteworthy Wednesday Option Activity: LAD, NEM, ABBV.NEWS2: Noteworthy Wednesday Option Activity: LAD, NEM, ABBV.NEWS3: 4 Big Drugmakers Boasting Impressive Oncology Pipelines.NEWS4: Why AbbVie (ABBV) is a Top Dividend Stock for Your Portfolio.
2019-09-12: NEWS1: Consumer groups, unions urge caution on $63 billion AbbVie deal for Allergan.NEWS2: Gilead Tops List of Most Innovative Drug Companies.NEWS3: Humira Sales Will Crash To $3 Billion — Why AbbVie Stock Got An Upgrade.NEWS4: Buy AbbVie Stock, Because Its Deal for Allergan Just Might Work, Analyst Says.NEWS5: AbbVie Stock Rises After UBS Upgrades To Buy.NEWS6: Anxious About AbbVie? Here Are 4 Things You Should Know.NEWS7: Anxious About AbbVie? Here Are 4 Things You Should Know.
2019-09-13: NEWS1: Dividend Growth ETFs for Long Term Investors.NEWS2: Vertex Gains Reimbursement for Orkambi & Symkevi in Scotland.
2019-09-16: NEWS1: AbbVie (ABBV) Gains As Market Dips: What You Should Know.NEWS2: AbbVie Inc. -- Moody's assigns Baa2 to AbbVie's euro notes; stable outlook.
2019-09-17: NEWS1: U.S. Senators urge FTC to scrutinize multi-billion dollar pharma mergers.NEWS2: Novartis Announces New Data on Spondylitis Drug Cosentyx.

Answer: Decrease